Skip to main content

Pfizer’s got its eye on more than the COVID-19 market

The company is already laying the groundwork for what it will look like when revenue from its COVID-19 franchise begins to wane.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.